.png)
AoPcasts: "The Consult" Bringing you the latest in medical research
Welcome to "The Consult," an academic podcast series hosted by Professor Paul Klenerman, Truelove Professor at the Nuffield Department of Medicine, University of Oxford. As part of the Associations of Physicians of Great Britain and Ireland (AoPGBI) podcast series, we engage with leading researchers who are continually advancing their fields through innovative basic science and clinical studies. Each episode offers an exploration of their current research, providing a unique and personal window onto the latest developments and their future trajectory.
Podcasting since 2021 • 12 episodes
AoPcasts: "The Consult" Bringing you the latest in medical research
Latest Episodes
PODCAST: How to plan your research
Reflecting on a distinguished and wide-ranging career as a clinician scientist, Professor Sir Mark Caulfield shares candid insights into the logistical, political and administrative challenges he has encountered along the way. From his early wo...
•
51:48
PODCAST: Fibromyalgia: New Paradigms in Etiopathogenesis
Fibromyalgia remains a challenging and often misunderstood condition, traditionally viewed through the lens of central sensitisation and chronic pain syndromes. However, emerging evidence is reshaping our understanding of its underlying mechani...
•
57:44
THE CONSULT: Professor Paul Klenerman talks with Professor Christopher Buckley about his recent papers.
These recent papers describe work in the field of stromal cell biology. Fibroblasts were long regarded as simple structural cells and often ignored by immunologists. In these studies of human disease Chris Buckley discusses how recent approache...
•
24:33
PODCAST: AI in Medicine: Promise and Paradox
Artificial Intelligence is transforming medicine, from diagnostics and drug discovery to personalised treatment and predictive analytics. But alongside its promise come some important challenges: Algorithmic bias, data privacy, accountability a...
•
1:00:03
THE CONSULT: A precision medicine approach to colorectal cancer prevention using the omega (n)-3 polyunsaturated fatty acid (PUFA) EPA
Mark Hull talks about the translational research development of the n-3 PUFA EPA as a cancer prevention agent through to phase 2 and 3 clinical trials, touching on design and delivery of trials of ‘nutraceuticals’ like high-dose n-3 PUFAs, and ...
•
47:10
